Trials / Sponsors / AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hematologic Malignancy | — | 2026-01-29 |
| Recruiting | Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B- Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma, Leukemia Relapse | Phase 1 / Phase 2 | 2026-01-06 |